glp 1 frequency Analysis & Commentary Frontiers | Exploring the multifaceted
Description
Short-acting GLP-1RAs (exenatide [ t 1/2 of 2.4 hours] and lixisenatide [ t 1/2 of 24 hours] administered before meals twice-daily and once-daily, respectively) exhibit intermittent GLP-1 receptor activation translating into potent deceleration of upper gastrointestinal motility, an effect which is sustained during prolonged treatment

Many people become more active after losing weight , which is generally very positive for health

Your treatment plan from your clinician will describe any additional active ingredients they have chosen to prescribe, as well as the reason for prescribing them
however, semaglutide is known to show higher GI side effects compared to others 12

You might notice your appetite increasing and your blood sugar levels rising